Determination of trans-2,4,3',4',5'-pentamethoxystilbene in rat plasma and its application to a pharmacokinetic study

Journal of Pharmaceutical and Biomedical Analysis

Volumn 57, Issue 1, 2012, Pages 94-98

  Lin, Hai Shu ^a   Spatafora, Carmela ^b   Tringali, Corrado ^b   Ho, Paul C ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Absolute oral bioavailability; HPLC; Pharmacokinetics; Trans 2,4,3',4',5' Pentamethoxystilbene

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2,4,3',4',5' PENTAMETHOXYSTILBENE; ANTINEOPLASTIC AGENT; FUNCTIONAL GROUP; METHYL BETA CYCLODEXTRIN; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; STANDARD; STRUCTURE ACTIVITY RELATION; SUSPENSION; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANS ISOMER;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HALF-LIFE; LIMIT OF DETECTION; MAGNETIC RESONANCE SPECTROSCOPY; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE STANDARDS; SOLUBILITY; STILBENES;

EID: 80054023836     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.08.020     Document Type: Article

References (20)

1. Baur J.A., Sinclair D.A. Nat. Rev. Drug Discov. 2006, 5:493-506.
2. Chun Y.J., Kim M.Y., Guengerich F.P. Biochem. Biophys. Res. Commun. 1999, 262:20-24.
3. Chang T.K., Lee W.B., Ko H.H. Can. J. Physiol. Pharmacol. 2000, 78:874-881.
4. Chun Y.J., Lim C., Ohk S.O., Lee J.M., Lee J.H., Choi S., Kim S. Med. Chem. Commun. 2011, doi:10.1039/c1030md00242a.
5. Li H., Wu W.K., Zheng Z., Che C.T., Yu L., Li Z.J., Wu Y.C., Cheng K.W., Yu J., Cho C.H., Wang M. Biochem. Pharmacol. 2009, 78:1224-1232.
6. Li H., Wu W.K., Li Z.J., Chan K.M., Wong C.C., Ye C.G., Yu L., Sung J.J., Cho C.H., Wang M. Br. J. Pharmacol. 2010, 160:1352-1361.
7. Remsberg C.M., Yanez J.A., Ohgami Y., Vega-Villa K.R., Rimando A.M., Davies N.M. Phytother. Res. 2008, 22:169-179.
8. Kapetanovic I.M., Muzzio M., Huang Z., Thompson T.N., McCormick D.L. Cancer Chemother. Pharmacol. 2011, 68:593-601.
9. Lin H.S., Choo Q.Y., Ho P.C. Biomed. Chromatogr. 2010, 24:1373-1378.
10. Lin H.S., Ho P.C. J. Pharm. Biomed. Anal. 2009, 49:387-392.
11. Lin H.S., Tringali C., Spatafora C., Choo Q.Y., Ho P.C. Chromatographia 2010, 72:827-832.
12. Lin H.S., Tringali C., Spatafora C., Wu C., Ho P.C. J. Pharm. Biomed. Anal. 2010, 51:679-684.
13. Lin H.S., Yue B.D., Ho P.C. Biomed. Chromatogr. 2009, 23:1308-1315.
14. Lin H.S., Zhang W., Go M.L., Choo Q.Y., Ho P.C. J. Pharm. Biomed. Anal. 2010, 53:693-697.
15. Lin H.S., Zhang W., Go M.L., Tringali C., Spatafora C., Ho P.C. J. Agric. Food. Chem. 2011, 59:1072-1077.
16. Das S., Lin H.S., Ho P.C., Ng K.Y. Pharm. Res. 2008, 25:2593-2600.
17. Lin H.S., Ho P.C. J. Pharm. Sci. 2011, 100:4491-4500.
18. Hurst S., Loi C.M., Brodfuehrer J., El-Kattan A. Expert. Opin. Drug Metab. Toxicol. 2007, 3:469-489.
19. Chan O.H., Stewart B.H. Drug Discov. Today 1996, 1:461-473.
20. Amidon G.L., Lennernas H., Shah V.P., Crison J.R. Pharm. Res. 1995, 12:413-420.